Reactome: A Curated Pathway Database
THIS SITE IS USED FOR CURATION AND TESTING
IT IS NOT STABLE, IS LINKED TO AN INCOMPLETE DATA SET, AND IS NOT MONITORED FOR PERFORMANCE. WE STRONGLY RECOMMEND THE USE OF OUR PUBLIC SITE

Query author contributions in Reactome

Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.

If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.

Name Email address

Details on Person Androgen Deficiency and Phosphodiesterase Type 5 Expression Changes in Aging Male: Therapeutic Implications

Class:IdLiteratureReference:9706800
_displayNameAndrogen Deficiency and Phosphodiesterase Type 5 Expression Changes in Aging Male: Therapeutic Implications
_timestamp2020-11-09 09:57:16
author[Person:9706726] Aversa, Antonio
[Person:9706783] Duca, Ylenia
[Person:9706743] Condorelli, Rosita Angela
[Person:9706776] Calogero, Aldo Eugenio
[Person:9706801] La Vignera, Sandro
created[InstanceEdit:9706780] Jassal, Bijay, 2020-11-09
journalFront Endocrinol (Lausanne)
pages225
pubMedIdentifier31110491
titleAndrogen Deficiency and Phosphodiesterase Type 5 Expression Changes in Aging Male: Therapeutic Implications
volume10
year2019
(literatureReference)[Reaction:9705926] AR binds AR agonists [Homo sapiens]
[Change default viewing format]
No pathways have been reviewed or authored by Androgen Deficiency and Phosphodiesterase Type 5 Expression Changes in Aging Male: Therapeutic Implications (9706800)